Lausanne Switzerland
Biographical Sketch: Benjamin J. Marsland obtained his Ph.D. from the Malaghan Institute of Medical Research, University of Otago, New Zealand, before becoming a postdoctoral fellow at the Swiss Federal Institute of Technology (ETH) in Zürich, Switzerland. He is now an associate professor and the Head of Research in the Respiratory Division of the University Hospital in Lausanne (CHUV), Switzerland. His research interests include the crossover between immunology and microbiology, particularly within the context of neonatal development and lung diseases.
http://www.chuv.ch/pneumologie/pne-microbiota.htm
Any personal financial relationships? No
I have disclosed to ICMI all relevant financial relationships, and hereby allow ICMI to disclose this information to learners in print. | |
I will include, as the first slide of any presentation, a full disclosure of any financial relationships that may influence my presentation. | |
The content and/or presentation of the information with which I am involved, including any presentation of therapeutic options, will be well-balanced, evidence-based, and will not promote specific proprietary business interests of a commercial interest. Any product identification will be made using the generic names to the extent possible. In addition, any off-label use of a medication will be specifically disclosed. | |
I have not and will not accept any additional honoraria, payments or reimbursements beyond that which has been agreed upon directly with ICMI. | |
1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity. | |
2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA). | |
3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products. | |
4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature". |
Neonatal Immune Cell Development in the Lung - Preprogrammed or Opportunities for Intervention?